Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 921

1.

Extracting allelic read counts from 250,000 human sequencing runs in Sequence Read Archive.

Tsui B, Dow M, Skola D, Carter H.

Pac Symp Biocomput. 2019;24:196-207.

2.

Computational KIR copy number discovery reveals interaction between inhibitory receptor burden and survival.

Pyke RM, Genolet R, Harari A, Coukos G, Gfeller D, Carter H.

Pac Symp Biocomput. 2019;24:148-159.

3.

Editorial Comment.

Carter HB.

J Urol. 2019 Mar 1:10109701JU000055438761658af. doi: 10.1097/01.JU.0000554387.61658.af. [Epub ahead of print] No abstract available.

PMID:
30821621
4.

Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence.

Liang H, Tsui BY, Ni H, Valentim CCS, Baxter SL, Liu G, Cai W, Kermany DS, Sun X, Chen J, He L, Zhu J, Tian P, Shao H, Zheng L, Hou R, Hewett S, Li G, Liang P, Zang X, Zhang Z, Pan L, Cai H, Ling R, Li S, Cui Y, Tang S, Ye H, Huang X, He W, Liang W, Zhang Q, Jiang J, Yu W, Gao J, Ou W, Deng Y, Hou Q, Wang B, Yao C, Liang Y, Zhang S, Duan Y, Zhang R, Gibson S, Zhang CL, Li O, Zhang ED, Karin G, Nguyen N, Wu X, Wen C, Xu J, Xu W, Wang B, Wang W, Li J, Pizzato B, Bao C, Xiang D, He W, He S, Zhou Y, Haw W, Goldbaum M, Tremoulet A, Hsu CN, Carter H, Zhu L, Zhang K, Xia H.

Nat Med. 2019 Mar;25(3):433-438. doi: 10.1038/s41591-018-0335-9. Epub 2019 Feb 11.

PMID:
30742121
5.

Correction: Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investment.

Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy JP, Casalegno S, Lambert G, Gaston K.

PLoS One. 2019 Feb 6;14(2):e0212101. doi: 10.1371/journal.pone.0212101. eCollection 2019.

6.

Novel Noninvasive Assessment of Microvascular Structure and Function in Humans.

Smith KJ, Argarini R, Carter HH, Quirk BC, Haynes A, Naylor LH, McKirdy H, Kirk RW, McLaughlin RA, Green DJ.

Med Sci Sports Exerc. 2019 Jan 24. doi: 10.1249/MSS.0000000000001898. [Epub ahead of print]

PMID:
30688767
7.

Exploring the landscape of focal amplifications in cancer using AmpliconArchitect.

Deshpande V, Luebeck J, Nguyen ND, Bakhtiari M, Turner KM, Schwab R, Carter H, Mischel PS, Bafna V.

Nat Commun. 2019 Jan 23;10(1):392. doi: 10.1038/s41467-018-08200-y.

8.

ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLS.

Lange JM, Gulati R, Leonardson AS, Lin DW, Newcomb LF, Trock BJ, Carter HB, Cooperberg MR, Cowan JE, Klotz LH, Etzioni R.

Ann Appl Stat. 2018 Sep;12(3):1773-1795. doi: 10.1214/17-AOAS1130. Epub 2018 Sep 11.

9.

Extended-release gabapentin for failed back surgery syndrome: results from a randomized double-blind cross-over study.

Gewandter JS, Frazer ME, Cai X, Chiodo VF, Rast SA, Dugan M, Carter HA, Rahmani R, Stone JJ, Markman JD.

Pain. 2019 Jan 7. doi: 10.1097/j.pain.0000000000001478. [Epub ahead of print]

PMID:
30624344
10.

Cohort study of a specialist social worker intervention on hospital use for patients at risk of long stay.

Osborne S, Harrison G, O'Malia A, Barnett AG, Carter HE, Graves N.

BMJ Open. 2018 Dec 22;8(12):e023127. doi: 10.1136/bmjopen-2018-023127.

11.

Evolutionary Pressure against MHC Class II Binding Cancer Mutations.

Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H.

Cell. 2018 Dec 13;175(7):1991. doi: 10.1016/j.cell.2018.11.050. No abstract available.

PMID:
30550793
12.

Integrating molecular networks with genetic variant interpretation for precision medicine.

Capriotti E, Ozturk K, Carter H.

Wiley Interdiscip Rev Syst Biol Med. 2018 Dec 12:e1443. doi: 10.1002/wsbm.1443. [Epub ahead of print] Review.

PMID:
30548534
13.

Identifying Driver Interfaces Enriched for Somatic Missense Mutations in Tumors.

Ozturk K, Carter H.

Methods Mol Biol. 2019;1907:51-72. doi: 10.1007/978-1-4939-8967-6_4.

PMID:
30542990
14.

Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life.

Johnson SR, Carter HE, Leo P, Hollingworth SA, Davis EA, Jones TW, Conwell LS, Harris M, Brown MA, Graves N, Duncan EL.

Diabetes Care. 2019 Jan;42(1):69-76. doi: 10.2337/dc18-0261. Epub 2018 Dec 6.

PMID:
30523035
15.

Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo.

Almanza G, Rodvold JJ, Tsui B, Jepsen K, Carter H, Zanetti M.

Sci Rep. 2018 Dec 4;8(1):17581. doi: 10.1038/s41598-018-35968-2.

16.

Comparison of Microbial Growth Between Commercial Formula and Blenderized Food for Tube Feeding.

Johnson TW, Milton DL, Johnson K, Carter H, Hurt RT, Mundi MS, Epp L, Spurlock AL.

Nutr Clin Pract. 2019 Apr;34(2):257-263. doi: 10.1002/ncp.10226. Epub 2018 Dec 3.

PMID:
30511371
17.

Relative Validity and Reproducibility of a Food Frequency Questionnaire to Assess Nutrients and Food Groups of Relevance to the Gut Microbiota in Young Children.

Leong C, Taylor RW, Haszard JJ, Fleming EA, Tannock GW, Szymlek-Gay EA, Cameron SL, Yu R, Carter H, Chee LK, Kennedy L, Moore R, Heath AM.

Nutrients. 2018 Nov 2;10(11). pii: E1627. doi: 10.3390/nu10111627.

18.

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.

Carter HB, Helfand B, Mamawala M, Wu Y, Landis P, Yu H, Wiley K, Na R, Shi Z, Petkewicz J, Shah S, Fantus RJ, Novakovic K, Brendler CB, Zheng SL, Isaacs WB, Xu J.

Eur Urol. 2018 Oct 8. pii: S0302-2838(18)30684-5. doi: 10.1016/j.eururo.2018.09.021. [Epub ahead of print]

PMID:
30309687
19.

Integrative genomic analysis of mouse and human hepatocellular carcinoma.

Dow M, Pyke RM, Tsui BY, Alexandrov LB, Nakagawa H, Taniguchi K, Seki E, Harismendy O, Shalapour S, Karin M, Carter H, Font-Burgada J.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):E9879-E9888. doi: 10.1073/pnas.1811029115. Epub 2018 Oct 4.

PMID:
30287485
20.

PTEN status assessment in the Johns Hopkins active surveillance cohort.

Tosoian JJ, Guedes LB, Morais CL, Mamawala M, Ross AE, De Marzo AM, Trock BJ, Han M, Carter HB, Lotan TL.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):176-181. doi: 10.1038/s41391-018-0093-2. Epub 2018 Oct 2.

PMID:
30279579
21.

Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investment.

Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy J, Casalegno S, Lambert G, Gaston K.

PLoS One. 2018 Sep 26;13(9):e0203694. doi: 10.1371/journal.pone.0203694. eCollection 2018. Erratum in: PLoS One. 2019 Feb 6;14(2):e0212101.

22.

Evolutionary Pressure against MHC Class II Binding Cancer Mutations.

Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H.

Cell. 2018 Oct 4;175(2):416-428.e13. doi: 10.1016/j.cell.2018.08.048. Epub 2018 Sep 20. Erratum in: Cell. 2018 Dec 13;175(7):1991.

PMID:
30245014
23.

Psoriasiform, Hyperpigmented Plaques of the Palms and Soles: Answer.

Tran TAN, Carter HC, Conte J, Carlson JA.

Am J Dermatopathol. 2018 Oct;40(10):780-781. doi: 10.1097/DAD.0000000000000899. No abstract available.

PMID:
30234562
24.

Retrospective Cohort Study on the Optimal Timing of Orogastric Tube/Nasogastric Tube Insertion in Infants With Pyloric Stenosis.

Lee LK, Burns RA, Dhamrait RS, Carter HF, Vadi MG, Grogan TR, Elashoff DA, Applegate RL 2nd, Iravani M.

Anesth Analg. 2018 Sep 18. doi: 10.1213/ANE.0000000000003805. [Epub ahead of print]

PMID:
30234537
25.

Exposure to trips and slips with increasing unpredictability while walking can improve balance recovery responses with minimum predictive gait alterations.

Okubo Y, Brodie MA, Sturnieks DL, Hicks C, Carter H, Toson B, Lord SR.

PLoS One. 2018 Sep 18;13(9):e0202913. doi: 10.1371/journal.pone.0202913. eCollection 2018.

26.

Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.

Buckley AR, Ideker T, Carter H, Harismendy O, Schork NJ.

Genome Med. 2018 Sep 14;10(1):69. doi: 10.1186/s13073-018-0579-5.

27.

Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer.

Huntley JH, Coley RY, Carter HB, Radhakrishnan A, Krakow M, Pollack CE.

Urology. 2018 Nov;121:118-124. doi: 10.1016/j.urology.2018.08.021. Epub 2018 Aug 30.

PMID:
30171924
28.

UBC-Nepal expedition: upper and lower limb conduit artery shear stress and flow-mediated dilation on ascent to 5,050 m in lowlanders and Sherpa.

Tremblay JC, Hoiland RL, Carter HH, Howe CA, Stembridge M, Willie CK, Gasho C, MacLeod DB, Pyke KE, Ainslie PN.

Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1532-H1543. doi: 10.1152/ajpheart.00345.2018. Epub 2018 Aug 31.

PMID:
30168724
29.

Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.

Druskin SC, Mamawala M, Tosoian JJ, Epstein JI, Pavlovich CP, Carter HB, Trock BJ.

J Urol. 2019 Jan;201(1):98-104. doi: 10.1016/j.juro.2018.08.023.

PMID:
30114397
30.

Contractile activity attenuates autophagy suppression and reverses mitochondrial defects in skeletal muscle cells.

Parousis A, Carter HN, Tran C, Erlich AT, Mesbah Moosavi ZS, Pauly M, Hood DA.

Autophagy. 2018;14(11):1886-1897. doi: 10.1080/15548627.2018.1491488. Epub 2018 Aug 4.

PMID:
30078345
31.

Germline mutations in PPFIBP2 are associated with lethal prostate cancer.

Wu Y, Yu H, Zheng SL, Feng B, Kapron AL, Na R, Boyle JL, Shah S, Shi Z, Ewing CM, Wiley KE, Luo J, Walsh PC, Carter HB, Helfand BT, Cooney KA, Xu J, Isaacs WB.

Prostate. 2018 Dec;78(16):1222-1228. doi: 10.1002/pros.23697. Epub 2018 Jul 24.

PMID:
30043417
32.

Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency Department.

Kiechle ES, McKenna CM, Carter H, Zeymo A, Gelfand BW, DeGeorge LM, Sauter DA, Mazer-Amirshahi M.

J Med Toxicol. 2018 Dec;14(4):272-277. doi: 10.1007/s13181-018-0671-7. Epub 2018 Jul 2.

PMID:
29968185
33.

The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.

Ozturk K, Dow M, Carlin DE, Bejar R, Carter H.

J Mol Biol. 2018 Sep 14;430(18 Pt A):2875-2899. doi: 10.1016/j.jmb.2018.06.016. Epub 2018 Jun 15. Review.

34.

Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer-Reply.

Patel HD, Tosoian JJ, Carter HB, Epstein JI.

JAMA Oncol. 2018 Aug 1;4(8):1133-1134. doi: 10.1001/jamaoncol.2018.0754. No abstract available.

PMID:
29852039
35.

Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.

Carter HB.

JAMA. 2018 May 8;319(18):1866-1868. doi: 10.1001/jama.2018.4914. No abstract available.

PMID:
29800999
36.

Autophagy and mitophagy flux in young and aged skeletal muscle following chronic contractile activity.

Carter HN, Kim Y, Erlich AT, Zarrin-Khat D, Hood DA.

J Physiol. 2018 Aug;596(16):3567-3584. doi: 10.1113/JP275998. Epub 2018 Jul 3.

PMID:
29781176
37.

Blended tube feeding prevalence, efficacy, and safety: What does the literature say?

Carter H, Johnson K, Johnson TW, Spurlock A.

J Am Assoc Nurse Pract. 2018 Mar;30(3):150-157. doi: 10.1097/JXX.0000000000000009. Review.

PMID:
29757883
38.

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.

Patel HD, Gupta M, Tosoian JJ, Carter HB, Partin AW, Epstein JI.

J Urol. 2018 Nov;200(5):1068-1074. doi: 10.1016/j.juro.2018.04.058. Epub 2018 Apr 17.

PMID:
29673946
39.

Public perceptions of emergency decontamination: Effects of intervention type and responder management strategy during a focus group study.

Carter H, Weston D, Betts N, Wilkinson S, Amlôt R.

PLoS One. 2018 Apr 13;13(4):e0195922. doi: 10.1371/journal.pone.0195922. eCollection 2018.

40.

Perspectives from the Third International Summit on Medical Nutrition Education and Research.

Crowley JJ, Laur C, Carter HDE, Jones G, Ray S.

Front Public Health. 2018 Mar 23;6:93. doi: 10.3389/fpubh.2018.00093. eCollection 2018.

41.

A global transcriptional network connecting noncoding mutations to changes in tumor gene expression.

Zhang W, Bojorquez-Gomez A, Velez DO, Xu G, Sanchez KS, Shen JP, Chen K, Licon K, Melton C, Olson KM, Yu MK, Huang JK, Carter H, Farley EK, Snyder M, Fraley SI, Kreisberg JF, Ideker T.

Nat Genet. 2018 Apr;50(4):613-620. doi: 10.1038/s41588-018-0091-2. Epub 2018 Apr 2.

42.

Effect of contractile activity on PGC-1α transcription in young and aged skeletal muscle.

Carter HN, Pauly M, Tryon LD, Hood DA.

J Appl Physiol (1985). 2018 Jun 1;124(6):1605-1615. doi: 10.1152/japplphysiol.01110.2017. Epub 2018 Mar 15.

PMID:
29543139
43.

A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.

Wu Y, Yu H, Zheng SL, Na R, Mamawala M, Landis T, Wiley K, Petkewicz J, Shah S, Shi Z, Novakovic K, McGuire M, Brendler CB, Ding Q, Helfand BT, Carter HB, Cooney KA, Isaacs WB, Xu J.

Prostate. 2018 Jun;78(8):607-615. doi: 10.1002/pros.23505. Epub 2018 Mar 9.

PMID:
29520813
44.

MHC-I genotype drives early immune selection of oncogenic mutations.

Marty R, de Prisco N, Carter H, Font-Burgada J.

Mol Cell Oncol. 2018 Jan 25;5(2):e1409863. doi: 10.1080/23723556.2017.1409863. eCollection 2018.

45.

HSP90: an unappreciated mediator of cutaneous vascular adaptation?

Carter HH, Green DJ.

J Appl Physiol (1985). 2018 Feb 1;124(2):521. doi: 10.1152/japplphysiol.00992.2017. No abstract available.

46.

Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving Practice.

Tosoian JJ, Carter HB.

Eur Urol. 2018 May;73(5):713-714. doi: 10.1016/j.eururo.2018.02.006. Epub 2018 Feb 17. No abstract available.

PMID:
29458984
47.

Integrated children's clinic care (ICCC) versus a self-directed care pathway for children with a chronic health condition: a multi-centre randomised controlled trial study protocol.

Frakking TT, Waugh J, Teoh HJ, Shelton D, Moloney S, Ward D, David M, Barber M, Carter H, Mickan S, Weir K.

BMC Pediatr. 2018 Feb 19;18(1):72. doi: 10.1186/s12887-018-1034-x.

48.

UBC-Nepal expedition: The use of oral antioxidants does not alter cerebrovascular function at sea level or high altitude.

Hansen AB, Hoiland RL, Lewis NCS, Tymko MM, Tremblay JC, Stembridge M, Nowak-Flück D, Carter HH, Bailey DM, Ainslie PN.

Exp Physiol. 2018 Apr 1;103(4):523-534. doi: 10.1113/EP086887. Epub 2018 Mar 8.

PMID:
29427527
49.

Localised cutaneous microvascular adaptation to exercise training in humans.

Atkinson CL, Carter HH, Thijssen DHJ, Birk GK, Cable NT, Low DA, Kerstens F, Meeuwis I, Dawson EA, Green DJ.

Eur J Appl Physiol. 2018 Apr;118(4):837-845. doi: 10.1007/s00421-018-3813-3. Epub 2018 Feb 7.

PMID:
29417205
50.

Sympatholysis: the more we learn, the less we know.

Gliemann L, Carter H.

J Physiol. 2018 Mar 15;596(6):963-964. doi: 10.1113/JP275513. Epub 2018 Feb 12. No abstract available.

Supplemental Content

Loading ...
Support Center